MCL Literature Feed

121 papers on mantle cell lymphoma from PubMed. Updated daily.

ADC BCL2i BTKi CAR-T CDK4/6i CNS MRD PI3Ki TP53-mutated biomarkers bispecific blastoid case report chemotherapy consolidation elderly epidemiology frontline genomics guidelines

A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma.

This phase 1 study established the safety and preliminary efficacy of a novel bortezomib, cladribine, and rituximab regimen for older, newly diagnosed mantle cell lymphoma patients.

Jeffrey J Pu, Kristin N Berger, Chunlei Zheng et al.·Frontiers in oncology·Jan 1, 2024

chemotherapy immunotherapy frontline elderly phase 1 toxicity

← PreviousPage 5 of 5